News & Events September

CTI Clinical Trial and Consulting Services Announces President and CEO, Timothy J. Schroeder, to Present at “The Practice of Transplant Administration” Workshop

September 26, 2011

Timothy J. Schroeder will present at “The Practice of Transplant Administration” Workshop, which takes place September 26-27, 2011 and is presented by The Transplant Management Group, LLC. Mr. Schroeder will present on the topic of the Economics of Clinical Trials and their Potential Contributions to the Transplant Program. Schroeder ...

Read More

Action Pharma’s phase IIb clinical trial with AP214 to prevent kidney injury associated with major cardiac surgery demonstrates positive top-line results

September 26, 2011

Action Pharma A/S today announced positive top-line results for its phase IIb AP214 trial in patients undergoing major cardiac surgery. The study demonstrated that AP214 is safe, reduces kidney injury, and improves long-term (90 days) outcomes on a composite end point (death, dialyses and kidney function) in patients undergoing cardiac ...

Read More

CTI Clinical Trial and Consulting Services Announces that John R. Edwards, MD has joined as Medical Director

September 16, 2011

CTI Clinical Trial and Consulting Services (CTI) announces the addition of John R. Edwards, MD as Medical Director. Dr. Edwards brings to CTI extensive clinical experience in hematology, oncology and stem cell therapy. Dr. Edwards comes to CTI from Lifeforce Cryobanks where he served as the President/COO/CMO of the ...

Read More

CTI Clinical Trial and Consulting Services Announces Dr. William Irish to Present at Food and Drug Administration Public Workshop

September 8, 2011

William Irish, PhD will present at the Food and Drug Administration (FDA) as part of the public workshop on the Effects of Ischemia Reperfusion Injury (IRI) on Outcomes in Kidney Transplant, taking place September 8-9, 2011. Dr. Irish will present on the topic of Cold Machine Perfusion versus Static Cold ...

Read More

September Newsletter - EMA Clinical Evaluation Reports

September 1, 2011

Read More

Join Our Mailing List